HUMANasdaq · Biological Products, (No Diagnostic Substances)

Humacyte, Inc.

Alert me on HUMA

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

Six months

After each filing

Sep 16 Buy Jones Keith Anthony Insider

1 week

−0.8%S&P +2.1%

1 month

−22.9%S&P +2.6%

3 months

Result in36 trading days

6 months

Result in99 trading days

Aug 22 Buy Jones Keith Anthony Insider

1 week

−9.2%S&P +0.5%

1 month

−14.6%S&P +0.8%

3 months

Result in20 trading days

6 months

Result in83 trading days

Aug 20 Buy Jones Keith Anthony Insider

1 week

+1.7%S&P +1.1%

1 month

−13.4%S&P +1.7%

3 months

Result in18 trading days

6 months

Result in81 trading days

Aug 5 Buy Sen. Thomas H Tuberville Senate

1 week

−22.5%S&P +1.2%

1 month

−14.8%S&P +0.2%

3 months

Result in8 trading days

6 months

Result in71 trading days

Aug 5 Sale Sen. Thomas H Tuberville Senate

1 week

−22.5%S&P +1.2%

1 month

−14.8%S&P +0.2%

3 months

Result in8 trading days

6 months

Result in71 trading days

Show all 9

May 21 Buy Constantino Michael T. Insider

1 week

+27.5%S&P +1.9%

1 month

−31.3%S&P −1.0%

3 months

−37.0%S&P +3.4%

6 months

Result in19 trading days

May 21 Buy Sebelius Kathleen Insider

1 week

+27.5%S&P +1.9%

1 month

−31.3%S&P −1.0%

3 months

−37.0%S&P +3.4%

6 months

Result in19 trading days

May 21 Sale Sander Dale A. Insider

1 week

+27.5%S&P +1.9%

1 month

−31.3%S&P −1.0%

3 months

−37.0%S&P +3.4%

6 months

Result in19 trading days

May 21 Sale Parikh Shamik J Insider

1 week

+27.5%S&P +1.9%

1 month

−31.3%S&P −1.0%

3 months

−37.0%S&P +3.4%

6 months

Result in19 trading days

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for HUMA

38 held · newest 538 held · newest 2

Loading the filings.

See all 38 filings for HUMA

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Signal history

No signal for this ticker yet. A signal is written when insider buying here scores one dot or more.

Stakes

Aug 14, 2026 Schedule 13D, amended

Fresenius Medical Care Holdings, Inc.: 4.9%, 13,603,235 shares

Jun 30, 2026 Schedule 13G, amended

BlackRock, Inc.: 1.5%, 4,092,430 shares

Jul 10, 2026 Schedule 13D, amended

Fresenius Medical Care Holdings, Inc.: 6.8%, 18,312,735 shares

Jun 12, 2026 Schedule 13G

Davidson Kempner Capital Management LP: 4.7%, 12,787,073 shares

Jun 12, 2026 Schedule 13D, amended

Fresenius Medical Care Holdings, Inc.: 6.8%, 18,312,735 shares

Apr 24, 2026 Schedule 13D, amended

Fresenius Medical Care Holdings, Inc.: 8.4%, 18,312,735 shares

Mar 20, 2026 Schedule 13D, amended

Fresenius Medical Care Holdings, Inc.: 8.4%, 18,312,735 shares

Jan 1, 2026 Schedule 13D, amended

Fresenius Medical Care Holdings, Inc.: 9.5%, 18,312,735 shares

Oct 8, 2025 Schedule 13D, amended

Fresenius Medical Care AG: 9.9%, 18,312,735 shares

Schedule 13D is filed within 5 business days of crossing 5 percent by an investor who may seek to influence the company. Schedule 13G is filed by a passive holder, and a large institution has up to 45 days after the quarter end.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

$50KQ4 2025

$50KQ1 2026

$50KQ2 2026

$50KQ3 2026

Unchanged from Q2 2026. Reported to the Senate each quarter by the firms it hires.Original report ↗

Read from LDA.gov between Sep 23, 2026 and Oct 21, 2026. Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.